Skip to main content
Tuesday 3 June 2025
twitter linkedin facebook rss
User account menu
  • Subscribe
Home
Pharmaphorum menu first category
  • News
  • Views & Analysis
  • Deep Dive
    • Research & Development
    • Market Access
    • Oncology
    • Artificial Intelligence
    • Patients & Partnerships
    • Commercialisation
    • Previous Editions
  • Webinars
  • Podcasts
  • Videos
  • White Papers
  • Events
Pharmaphorum
close
    SECTION
    • News
    • Views & Analysis
    • Deep Dive
      • Research & Development
      • Market Access
      • Oncology
      • Artificial Intelligence
      • Patients & Partnerships
      • Commercialisation
      • Previous Editions
    • Webinars
    • Podcasts
    • Videos
    • White Papers
    • Events
Channels
    Channels
    • Sales & Marketing
    • R&D
    • Digital
    • Market Access
    • Oncology
    • Patients
    • Spotlight On
Channels
  • Sales & Marketing
  • R&D
  • Digital
  • Market Access
  • Oncology
  • Patients
  • Spotlight On
    SUB NAVIGATION
    • Live Coverage
    • Partner Content
    • About us
    • Work for us
    • Contribute
    • Contact us
    • Advertise

Newsletters and Deep Dive digital magazine

 
 
Sign up
twitter linkedin facebook rss
Sign in

Exclusive coverage of the 2016 inaugural 'Inspiring Hope' Ideathon

Views & Analysis
INC ideathon event
profile-mask
Adam Jeffery
25 September, 2016

2016

FacebookXLinkedin
Bookmark this

Oncology
ASCO 2025 Karen Rodriguez-Lorenc

Regeneron at ASCO 25: Advancing multiple myeloma treatment

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Market Access
Bridging research and clinical guidelines
Sponsored

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

R&D
Deep Dive's research and development 2025 edition out now banner

Deep Dive: Research and Development 2025

Every breakthrough in medicine, every new treatment that changes lives, starts with research. 

R&D
Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Oncology
ASCO 2025 Dr Vincent Picozzi

Disrupting cancer cell division: How tumour treating fields ...

Discover how Tumour Treating Fields are transforming pancreatic cancer treatment with insights from Dr. Vincent Picozzi at ASCO 2025.

Oncology
Life Sciences Industry Report - Part 5 feature image

Life Sciences Industry Report - Oncology

Developments in the oncology space in 2024 brought hope to both industry and patients.

Digital
New Jersey skyline
Partner Content

Axtria Ignite 2025: Leading in an Agentic Era

Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This

Patients
Operationalize: Expanded Access Programs comes to the West Coast!
Partner Content

Operationalize: Expanded Access Programs comes to the West C...

Improving Global Access to Life-Changing Therapeutics...

 
 

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

2016

clinical trials

ideathon

INC

patient engagement

Category : Views & Analysis / Clinical

Editor's Picks

  1. Astellas adds to claudin clout with $1.3bn+ Evopoint deal
  2. ASCO 25: Regeneron hails Libtayo's adjuvant data in CSCC
  3. ASCO 25: Gilead eyes first-line use of Trodelvy in TNBC
  4. Moderna's $760m-plus flu vaccine contracts are nixed by HHS
  5. MSD and Daiichi Sankyo pull HER3-DXd's FDA filing
Oncology
ASCO 2025 Karen Rodriguez-Lorenc

Regeneron at ASCO 25: Advancing multiple myeloma treatment

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Market Access
Bridging research and clinical guidelines
Sponsored

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

Pharmaphorum Menu
  • Digital
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Market Access
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Oncology
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Patients
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • R&D
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Sales & Marketing
    • News
    • Views & Analysis
    • Deep Dive
    • Webinars
    • Podcasts
    • Video
    • White Papers
    • Event
  • Spotlight on
    • ASCO 2025
    • Frontiers Health 2024
    • Life Science Industry Report
    • World Without Disease Summit

Sign up for email newsletters and Deep Dive

Subscribe
 
 
rss facebook linkedin twitter
Pharmaphorum
About us Advertising Contact us
Contribute Cookie Policy Privacy Policy
Terms & Conditions Work for us
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company
The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company